Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD is a research paper published in Clinical Gastroenterology and Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK119460
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P30DK120515
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK106419
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK121378
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK124318
National Institute of Environmental Health Sciences
Grant: 5P42ES010337
National Institute of Environmental Health Sciences
Grant: U01DK61734
U.S. Department of Defense
Grant: CA170674P2
NIEHS NIH HHS
Grant: P42 ES010337
NIDDK NIH HHS
Grant: U01 DK061734
AstraZeneca
Eli Lilly and Company
Uehara Memorial Foundation
Gilead Sciences
Arrowhead Pharmaceuticals
Boehringer Ingelheim
National Heart, Lung, and Blood Institute
Allergan
Bristol-Myers Squibb
Siemens USA
National Institutes of Health
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals